Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review)

Mol Med Rep. 2022 Jul;26(1):233. doi: 10.3892/mmr.2022.12749. Epub 2022 May 26.

Abstract

Nitric oxide, carbon monoxide and hydrogen sulfide are three endogenous gasotransmitters that serve a role in regulating normal and pathological cellular activities. They can stimulate or inhibit cancer cell proliferation and invasion, as well as interfere with cancer cell responses to drug treatments. Understanding the molecular pathways governing the interactions between these gases and the tumor microenvironment can be utilized for the identification of a novel technique to disrupt cancer cell interactions and may contribute to the conception of effective and safe cancer therapy strategies. The present review discusses the effects of these gases in modulating the action of chemotherapies, as well as prospective pharmacological and therapeutic interfering approaches. A deeper knowledge of the mechanisms that underpin the cellular and pharmacological effects, as well as interactions, of each of the three gases could pave the way for therapeutic treatments and translational research.

Keywords: H2S; NO; TME; cancer chemotherapy; gasotransmitter.

Publication types

  • Review

MeSH terms

  • Carbon Monoxide / metabolism
  • Carbon Monoxide / therapeutic use
  • Gasotransmitters* / therapeutic use
  • Humans
  • Hydrogen Sulfide* / metabolism
  • Hydrogen Sulfide* / pharmacology
  • Hydrogen Sulfide* / therapeutic use
  • Neoplasms* / drug therapy
  • Nitric Oxide / metabolism
  • Prospective Studies
  • Tumor Microenvironment

Substances

  • Gasotransmitters
  • Nitric Oxide
  • Carbon Monoxide
  • Hydrogen Sulfide

Grants and funding

Funding: No funding was received.